Citadel Advisors - CHAMPIONS ONCOLOGY INC ownership

CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 32 filers reported holding CHAMPIONS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHAMPIONS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$104,073
-83.8%
16,732
-83.6%
0.00%
Q2 2023$642,932
+494.9%
102,215
+280.2%
0.00%
Q1 2023$108,074
-50.1%
26,884
-44.0%
0.00%
Q4 2022$216,557
-88.1%
48,017
-80.2%
0.00%
Q3 2022$1,820,000
-4.6%
242,613
+2.8%
0.00%
Q2 2022$1,908,000
+14.9%
235,897
+15.5%
0.00%
Q1 2022$1,661,000
+8205.0%
204,279
+1612.5%
0.00%
Q3 2016$20,00011,9290.00%
Other shareholders
CHAMPIONS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Battery Partners IX, LLC 1,953,549$10,451,0003.89%
NEA Management Company, LLC 1,562,500$8,359,0000.55%
Perceptive Advisors 745,194$3,986,0000.16%
Par Capital Management 833,333$4,458,0000.09%
SABBY MANAGEMENT, LLC 169,397$893,0000.04%
Alexandria Capital, LLC 1,188$6,0000.00%
MORGAN STANLEY 2,690$14,0000.00%
Tower Research Capital LLC (TRC) 47$00.00%
UBS Group AG 483$3,0000.00%
BANK OF AMERICA CORP /DE/ 2,089$11,0000.00%
View complete list of CHAMPIONS ONCOLOGY INC shareholders